Cargando…
Pseudoscience and fraudulent products for COVID-19 management
As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely throughout the world. Additionally, new variants of the mutated viral variants have been found in some countries that are more dangerous than the original strain. Even vaccines cannot produce complete protective immunit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282830/ https://www.ncbi.nlm.nih.gov/pubmed/35836045 http://dx.doi.org/10.1007/s11356-022-21967-4 |
_version_ | 1784747196242984960 |
---|---|
author | Chavda, Vivek P. Sonak, Shreya S. Munshi, Nafesa K. Dhamade, Pooja N. |
author_facet | Chavda, Vivek P. Sonak, Shreya S. Munshi, Nafesa K. Dhamade, Pooja N. |
author_sort | Chavda, Vivek P. |
collection | PubMed |
description | As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely throughout the world. Additionally, new variants of the mutated viral variants have been found in some countries that are more dangerous than the original strain. Even vaccines cannot produce complete protective immunity against the newer strains of SARS-CoV-2. Due to such a dreadful situation, lots of fear and depression have been created among the public. People are looking for the treatment of the disease at any cost and there is a race in the market to provide treatment and make money, whether it is effective or not! In such a condition, many fraud products, remedies, and myths have come into the market, which is falsely claimed to be effective for the disease and can harm the patients. Hence, FDA has banned such products and remedies. In this review, we have compiled all such fraudulent and pseudosciences identified for COVID-19. Currently, in the pandemic time, health agencies are approving the repurposed medicines based on the small-scale clinical data for emergency uses that become ineffective (most of the cases) after large randomized clinical studies. Proper vigilance strategies need to be defined by the regulatory agencies of the nation and routine awareness programs shall be arranged for educating the people and healthcare workers on routine updates. |
format | Online Article Text |
id | pubmed-9282830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-92828302022-07-15 Pseudoscience and fraudulent products for COVID-19 management Chavda, Vivek P. Sonak, Shreya S. Munshi, Nafesa K. Dhamade, Pooja N. Environ Sci Pollut Res Int Review Article As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely throughout the world. Additionally, new variants of the mutated viral variants have been found in some countries that are more dangerous than the original strain. Even vaccines cannot produce complete protective immunity against the newer strains of SARS-CoV-2. Due to such a dreadful situation, lots of fear and depression have been created among the public. People are looking for the treatment of the disease at any cost and there is a race in the market to provide treatment and make money, whether it is effective or not! In such a condition, many fraud products, remedies, and myths have come into the market, which is falsely claimed to be effective for the disease and can harm the patients. Hence, FDA has banned such products and remedies. In this review, we have compiled all such fraudulent and pseudosciences identified for COVID-19. Currently, in the pandemic time, health agencies are approving the repurposed medicines based on the small-scale clinical data for emergency uses that become ineffective (most of the cases) after large randomized clinical studies. Proper vigilance strategies need to be defined by the regulatory agencies of the nation and routine awareness programs shall be arranged for educating the people and healthcare workers on routine updates. Springer Berlin Heidelberg 2022-07-14 2022 /pmc/articles/PMC9282830/ /pubmed/35836045 http://dx.doi.org/10.1007/s11356-022-21967-4 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Chavda, Vivek P. Sonak, Shreya S. Munshi, Nafesa K. Dhamade, Pooja N. Pseudoscience and fraudulent products for COVID-19 management |
title | Pseudoscience and fraudulent products for COVID-19 management |
title_full | Pseudoscience and fraudulent products for COVID-19 management |
title_fullStr | Pseudoscience and fraudulent products for COVID-19 management |
title_full_unstemmed | Pseudoscience and fraudulent products for COVID-19 management |
title_short | Pseudoscience and fraudulent products for COVID-19 management |
title_sort | pseudoscience and fraudulent products for covid-19 management |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282830/ https://www.ncbi.nlm.nih.gov/pubmed/35836045 http://dx.doi.org/10.1007/s11356-022-21967-4 |
work_keys_str_mv | AT chavdavivekp pseudoscienceandfraudulentproductsforcovid19management AT sonakshreyas pseudoscienceandfraudulentproductsforcovid19management AT munshinafesak pseudoscienceandfraudulentproductsforcovid19management AT dhamadepoojan pseudoscienceandfraudulentproductsforcovid19management |